Novel |
SLC6A4 |
solute carrier family 6 member 4 |
- Serotonin clearance from the synaptic cleft
- SLC-mediated transport of neurotransmitters
|
- Fluvoxamine
- Amphetamine
- Phentermine
- Tramadol
- Citalopram
- Benzatropine
- Venlafaxine
- Atomoxetine
- Amitriptyline
- Protriptyline
- Loxapine
- Meperidine
- Imipramine
- Fluoxetine
- Duloxetine
- Dextromethorphan
- Nortriptyline
- Amoxapine
- Fenfluramine
- Mazindol
- Trazodone
- Verapamil
- Paroxetine
- Trimipramine
- Minaprine
- Pseudoephedrine
- Cocaine
- Cyclobenzaprine
- Dopamine
- Sertraline
- Sibutramine
- Chlorpheniramine
- Doxepin
- Nefazodone
- Desipramine
- Escitalopram
- Dexfenfluramine
- Aripiprazole
- Clomipramine
- Ephedra sinica root
- MMDA
- Midomafetamine
- 4-Methoxyamphetamine
- Metamfetamine
- Nomifensine
- Zimelidine
- Amineptine
- Bicifadine
- Milnacipran
- OPC-14523
- CRx-119
- Amitifadine
- Lumateperone
- Mianserin
- Tesofensine
- Tapentadol
- Vilazodone
- Desvenlafaxine
- Dexmethylphenidate
- Serotonin
- Levomilnacipran
- Butriptyline
- Vortioxetine
- Dosulepin
- Nisoxetine
- Lorpiprazole
- Zotepine
- Dasotraline
|
|
Novel |
TCF4 |
transcription factor 4 |
- Myogenesis
- Myogenesis
- TGFBR3 expression
|
|
- Pitt-Hopkins syndrome, including: Pitt-Hopkins syndrome; Pitt-Hopkins-like syndrome
|
|
ABTB1 |
ankyrin repeat and BTB domain containing 1 |
|
|
|
|
ACVR1B |
activin A receptor type 1B |
- Signaling by NODAL
- Regulation of signaling by NODAL
- Signaling by Activin
|
|
|
|
AFDN |
afadin, adherens junction formation factor |
|
- (5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one
|
|
|
AKT1 |
AKT serine/threonine kinase 1 |
- Activation of BAD and translocation to mitochondria
- PIP3 activates AKT signaling
- PIP3 activates AKT signaling
- Downregulation of ERBB2:ERBB3 signaling
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
- MTOR signalling
- AKT phosphorylates targets in the cytosol
- AKT phosphorylates targets in the cytosol
- AKT phosphorylates targets in the nucleus
- Negative regulation of the PI3K/AKT network
- eNOS activation
- AKT-mediated inactivation of FOXO1A
- Integrin signaling
- Deactivation of the beta-catenin transactivating complex
- CD28 dependent PI3K/Akt signaling
- Co-inhibition by CTLA4
- G beta:gamma signalling through PI3Kgamma
- Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
- KSRP (KHSRP) binds and destabilizes mRNA
- VEGFR2 mediated vascular permeability
- TP53 Regulates Metabolic Genes
- Constitutive Signaling by AKT1 E17K in Cancer
- Interleukin-4 and Interleukin-13 signaling
- Regulation of TP53 Degradation
- Regulation of TP53 Activity through Acetylation
- Regulation of TP53 Activity through Association with Co-factors
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- Cyclin E associated events during G1/S transition
- Cyclin A:Cdk2-associated events at S phase entry
- PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
- RAB GEFs exchange GTP for GDP on RABs
- RUNX2 regulates genes involved in cell migration
- Regulation of PTEN stability and activity
- Extra-nuclear estrogen signaling
- Negative regulation of NOTCH4 signaling
- FLT3 Signaling
- Regulation of localization of FOXO transcription factors
- Estrogen-dependent nuclear events downstream of ESR-membrane signaling
- KEAP1-NFE2L2 pathway
- SARS-CoV-2 targets host intracellular signalling and regulatory pathways
- Mitochondrial unfolded protein response (UPRmt)
- High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
- High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
- Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
|
- ATP
- Arsenic trioxide
- Genistein
- Inositol 1,3,4,5-Tetrakisphosphate
- Resveratrol
- Archexin
- Enzastaurin
- Perifosine
- N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
|
- PTEN hamartoma tumor syndrome (PHTS), including: Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Proteus syndrome; Proteus-like syndrome
|
|
ANAPC10 |
anaphase promoting complex subunit 10 |
- Inactivation of APC/C via direct inhibition of the APC/C complex
- APC/C:Cdc20 mediated degradation of Cyclin B
- Autodegradation of Cdh1 by Cdh1:APC/C
- APC/C:Cdc20 mediated degradation of Securin
- APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
- Cdc20:Phospho-APC/C mediated degradation of Cyclin A
- Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
- Regulation of APC/C activators between G1/S and early anaphase
- APC/C:Cdc20 mediated degradation of mitotic proteins
- Phosphorylation of the APC/C
- APC-Cdc20 mediated degradation of Nek2A
- Separation of Sister Chromatids
- Senescence-Associated Secretory Phenotype (SASP)
- Assembly of the pre-replicative complex
- CDK-mediated phosphorylation and removal of Cdc6
- Transcriptional Regulation by VENTX
- Aberrant regulation of mitotic exit in cancer due to RB1 defects
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
ANAPC2 |
anaphase promoting complex subunit 2 |
- Inactivation of APC/C via direct inhibition of the APC/C complex
- APC/C:Cdc20 mediated degradation of Cyclin B
- Autodegradation of Cdh1 by Cdh1:APC/C
- APC/C:Cdc20 mediated degradation of Securin
- APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
- Cdc20:Phospho-APC/C mediated degradation of Cyclin A
- Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
- Regulation of APC/C activators between G1/S and early anaphase
- APC/C:Cdc20 mediated degradation of mitotic proteins
- Phosphorylation of the APC/C
- APC-Cdc20 mediated degradation of Nek2A
- Separation of Sister Chromatids
- Senescence-Associated Secretory Phenotype (SASP)
- Assembly of the pre-replicative complex
- CDK-mediated phosphorylation and removal of Cdc6
- Transcriptional Regulation by VENTX
- Aberrant regulation of mitotic exit in cancer due to RB1 defects
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
ANK3 |
ankyrin 3 |
- Interaction between L1 and Ankyrins
- Interaction between L1 and Ankyrins
- COPI-mediated anterograde transport
- Regulation of CDH1 posttranslational processing and trafficking to plasma membrane
|
|
|
|
ANP32B |
acidic nuclear phosphoprotein 32 family member B |
|
|
|
|
ANP32E |
acidic nuclear phosphoprotein 32 family member E |
|
|
|
|
ANTXR2 |
ANTXR cell adhesion molecule 2 |
|
|
- Infantile systemic hyalinosis and juvenile hyaline fibromatosis
|
|
AP1B1 |
adaptor related protein complex 1 subunit beta 1 |
- Nef mediated downregulation of MHC class I complex cell surface expression
- MHC class II antigen presentation
- Lysosome Vesicle Biogenesis
- Golgi Associated Vesicle Biogenesis
|
|
|
|
ARFGAP3 |
ARF GTPase activating protein 3 |
- COPI-mediated anterograde transport
- COPI-dependent Golgi-to-ER retrograde traffic
- CDC42 GTPase cycle
- RHOG GTPase cycle
|
|
|
|
ARHGEF6 |
Rac/Cdc42 guanine nucleotide exchange factor 6 |
- NRAGE signals death through JNK
- G alpha (12/13) signalling events
- Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
- G beta:gamma signalling through CDC42
- CDC42 GTPase cycle
- RAC1 GTPase cycle
- RHOU GTPase cycle
|
|
- Non-syndromic X-linked mental retardation
|
|
ARL4D |
ARF like GTPase 4D |
|
|
|
|
ATP5ME |
ATP synthase membrane subunit e |
- Formation of ATP by chemiosmotic coupling
- Cristae formation
|
|
|
|
AXIN1 |
axin 1 |
- Degradation of beta-catenin by the destruction complex
- Beta-catenin phosphorylation cascade
- TCF dependent signaling in response to WNT
- Degradation of AXIN
- Disassembly of the destruction complex and recruitment of AXIN to the membrane
- Disassembly of the destruction complex and recruitment of AXIN to the membrane
- Signaling by GSK3beta mutants
- CTNNB1 S33 mutants aren't phosphorylated
- CTNNB1 S37 mutants aren't phosphorylated
- CTNNB1 S45 mutants aren't phosphorylated
- CTNNB1 T41 mutants aren't phosphorylated
- APC truncation mutants have impaired AXIN binding
- AXIN missense mutants destabilize the destruction complex
- Truncations of AMER1 destabilize the destruction complex
- Ub-specific processing proteases
- RUNX1 regulates estrogen receptor mediated transcription
- RUNX1 regulates transcription of genes involved in WNT signaling
- Estrogen-dependent gene expression
|
|
- Caudal duplication anomaly
- Hepatocellular carcinoma
|
|
BAZ1A |
bromodomain adjacent to zinc finger domain 1A |
|
|
|
|
BECN1 |
beclin 1 |
- ISG15 antiviral mechanism
- Macroautophagy
- Ub-specific processing proteases
- Translation of Replicase and Assembly of the Replication Transcription Complex
- Translation of Replicase and Assembly of the Replication Transcription Complex
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- Antigen Presentation: Folding, assembly and peptide loading of class I MHC
- RSV-host interactions
|
- Estradiol
- Estradiol acetate
- Estradiol benzoate
- Estradiol cypionate
- Estradiol dienanthate
- Estradiol valerate
|
|